Characterization and identification of eight designer benzodiazepine metabolites by incubation with human liver microsomes and analysis by a triple quadrupole mass spectrometer

Identification of main human urinary metabolites of the designer nitrobenzodiazepines clonazolam, meclonazepam, and nifoxipam by nano-liquid chromatography-high-resolution mass spectrometry for drug testing purposes

(2016) Markus R. Meyer et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays

(2016) Madeleine Pettersson Bergstrand et al.   Drug Testing and Analysis

Development and application of a multi-component LC–MS/MS method for determination of designer benzodiazepines in urine

(2016) Madeleine Pettersson Bergstrand et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Characterization andin vitrophase I microsomal metabolism of designer benzodiazepines - an update comprising adinazolam, cloniprazepam, fonazepam, 3-hydroxyphenazepam, metizolam and nitrazolam

(2016) Bjoern Moosmann et al.   JOURNAL OF MASS SPECTROMETRY

Characterization of the four designer benzodiazepines clonazolam, deschloroetizolam, flubromazolam, and meclonazepam, and identification of their in vitro metabolites

(2015) Laura M. Huppertz et al.   Forensic Toxicology

The pharmacology and toxicology of kratom: from traditional herb to drug of abuse

(2015) Marcus L. Warner et al.   INTERNATIONAL JOURNAL OF LEGAL MEDICINE

Identification of Metabolite Biomarkers of the Designer Hallucinogen 25I-NBOMe in Mouse Hepatic Microsomal Preparations and Human Urine Samples Associated with Clinical Intoxication

(2015) Justin L. Poklis et al.   JOURNAL OF ANALYTICAL TOXICOLOGY

Designer benzodiazepines: A new challenge

(2015) Bjoern Moosmann et al.   World Psychiatry

Characterization of the designer benzodiazepine diclazepam and preliminary data on its metabolism and pharmacokinetics

(2014) Bjoern Moosmann et al.   Drug Testing and Analysis

Characterization of the designer benzodiazepine pyrazolam and its detectability in human serum and urine

(2013) Bjoern Moosmann et al.   Forensic Toxicology

Urinary Detection Times and Excretion Patterns of Flunitrazepam and its Metabolites After A Single Oral Dose

(2013) M. Forsman et al.   JOURNAL OF ANALYTICAL TOXICOLOGY

Detection and identification of the designer benzodiazepine flubromazepam and preliminary data on its metabolism and pharmacokinetics

(2013) Bjoern Moosmann et al.   JOURNAL OF MASS SPECTROMETRY

Polydrug abuse: A review of opioid and benzodiazepine combination use

(2012) Jermaine D. Jones et al.   DRUG AND ALCOHOL DEPENDENCE

General unknown screening procedure for the characterization of human drug metabolites in forensic toxicology: Applications and constraints

(2009) François-Ludovic Sauvage et al.   JOURNAL OF SEPARATION SCIENCE

Two-injection workflow for a liquid chromatography/LTQ-Orbitrap system to completein vivobiotransformation characterization: demonstration with buspirone metabolite identification

(2009) Austin C. Li et al.   RAPID COMMUNICATIONS IN MASS SPECTROMETRY

Case report: Etizolam and its major metabolites in two unnatural death cases

(2008) Takuma Nakamae et al.   FORENSIC SCIENCE INTERNATIONAL

Chemical submission: results of 4-year French inquiry

(2008) S. Djezzar et al.   INTERNATIONAL JOURNAL OF LEGAL MEDICINE